Monoclonal antibodies and side-effect management.

Oncology (Williston Park)

National Institutes of Health, Clinical Center, Nursing and Patient Care Services, Bethesda, Maryland 20892, USA.

Published: September 2006

Monoclonal antibodies are increasingly becoming a standard part of clinical cancer treatment. Eight monoclonal antibodies are approved by the Food and Drug Administration for the treatment of cancer in the United States. Oncology nurses are expected to be familiar with these agents, their indications, and their adverse effects, to provide appropriate care and symptom management to patients receiving these agents, and to adequately educate patients and families about these treatments and their specific and overlapping side effects. Monoclonal antibody mechanisms of action and indications, infusion guidelines, and symptom management are outlined in this article.

Download full-text PDF

Source

Publication Analysis

Top Keywords

monoclonal antibodies
12
symptom management
8
monoclonal
4
antibodies side-effect
4
side-effect management
4
management monoclonal
4
antibodies increasingly
4
increasingly standard
4
standard clinical
4
clinical cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!